Alexander A. Fitzpatrick, Chief Legal Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 3,355 shares at $10.00 ($34K) on 2026-06-12, disclosed to the SEC on 2026-06-12.
Scheduled sale ($34k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EVFM | BUY | 2021-12-20 | $10K | — | Filing → |
| EVFM | BUY | 2021-06-10 | $10K | — | Filing → |
| EVFM | BUY | 2020-11-18 | $20K | — | Filing → |